Table 1.
Clinical characteristics of the study subjects (n = 86)
| Variables | Frequency | Percent |
|---|---|---|
| First presented with DKA | ||
| Yes | 83 | 96.5 |
| No | 3 | 3.5 |
| Diabetic Duration | ||
| 2–5 years | 35 | 40.7 |
| 6–10 years | 36 | 41.9 |
| > 10 years | 15 | 17.4 |
| Frequency of DKA since diagnosis | ||
| 1 | 64 | 74.4 |
| 2 | 17 | 19.8 |
| 3 and above | 5 | 5.8 |
| Diabetic nephropathy | ||
| Yes | 0 | 0 |
| No | 11 | 12.8 |
| Never been screened | 75 | 87.2 |
| Neuropathy | ||
| Yes | 4 | 4.7 |
| No | 84 | 95.3 |
| Previous retinopathy screening | ||
| Yes | 21 | 24.4 |
| No | 65 | 75.6 |
| Body mass index | ||
| Under weight | 24 | 27.9 |
| Normal | 62 | 72.1 |
| Over weight | 0 | 0 |
| Height for age | ||
| Normal | 69 | 80.5 |
| Stunted | 17 | 19.5 |
| Hypertension | ||
| Yes | 1 | 1.16 |
| No | 85 | 98.84 |
| Visual acuity | ||
| Normal | 68 | 79.1 |
| Abnormal | 18 | 20.9 |
| Glycemic control | ||
| Good | 41 | 47.7 |
| Poor | 45 | 52.3 |
| Retinopathy | ||
| Yes | 4 | 4.7 |
| No | 82 | 95.3 |
| Stage of retinopathy | ||
| Background/nonproliferative | 4 | 100 |
| Proliferative | 0 | 0 |
| Maculopathy | 2 | 50 |
DKA Diabetic ketoacidosis